1. Home
  2. GPCR vs UCTT Comparison

GPCR vs UCTT Comparison

Compare GPCR & UCTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • UCTT
  • Stock Information
  • Founded
  • GPCR 2016
  • UCTT 1991
  • Country
  • GPCR United States
  • UCTT United States
  • Employees
  • GPCR N/A
  • UCTT N/A
  • Industry
  • GPCR
  • UCTT Semiconductors
  • Sector
  • GPCR
  • UCTT Technology
  • Exchange
  • GPCR Nasdaq
  • UCTT Nasdaq
  • Market Cap
  • GPCR 1.1B
  • UCTT 1.0B
  • IPO Year
  • GPCR 2023
  • UCTT 2004
  • Fundamental
  • Price
  • GPCR $19.01
  • UCTT $25.09
  • Analyst Decision
  • GPCR Strong Buy
  • UCTT Strong Buy
  • Analyst Count
  • GPCR 7
  • UCTT 4
  • Target Price
  • GPCR $76.17
  • UCTT $43.25
  • AVG Volume (30 Days)
  • GPCR 684.5K
  • UCTT 556.1K
  • Earning Date
  • GPCR 08-07-2025
  • UCTT 07-28-2025
  • Dividend Yield
  • GPCR N/A
  • UCTT N/A
  • EPS Growth
  • GPCR N/A
  • UCTT N/A
  • EPS
  • GPCR N/A
  • UCTT 0.62
  • Revenue
  • GPCR N/A
  • UCTT $2,138,500,000.00
  • Revenue This Year
  • GPCR N/A
  • UCTT N/A
  • Revenue Next Year
  • GPCR N/A
  • UCTT $1.85
  • P/E Ratio
  • GPCR N/A
  • UCTT $40.53
  • Revenue Growth
  • GPCR N/A
  • UCTT 20.21
  • 52 Week Low
  • GPCR $13.22
  • UCTT $16.66
  • 52 Week High
  • GPCR $47.48
  • UCTT $56.47
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 33.96
  • UCTT 65.50
  • Support Level
  • GPCR $18.50
  • UCTT $24.32
  • Resistance Level
  • GPCR $19.40
  • UCTT $25.82
  • Average True Range (ATR)
  • GPCR 1.18
  • UCTT 1.04
  • MACD
  • GPCR -0.17
  • UCTT 0.25
  • Stochastic Oscillator
  • GPCR 9.86
  • UCTT 88.43

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.

Share on Social Networks: